ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Merck Millipore, the life sciences division of Germany’s Merck KGaA, will acquire Amnis, a Seattle-based maker of high-speed cell-imaging instrumentation. Using the acquired technology, Millipore will combine flow cytometry and imaging analysis in a single system. Amnis has 40 employees and had sales of $14 million last year. “With Amnis we acquire a business with a talented workforce, a strong intellectual property position, and unique know-how,” says Jonathan DiVincenzo, head of Merck Millipore’s bioscience business.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter